Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$410,395
-$66,038 QoQ
Shares Held
17,043
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,891
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. PFE ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
This page
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,395 | 17,043 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $476,433 | 16,967 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $419,141 | 16,833 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $366,173 | 14,371 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $340,426 | 14,044 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $392,161 | 15,476 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $681,476 | 25,687 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $775,476 | 26,796 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $736,041 | 26,306 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $720,501 | 25,964 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $817,232 | 28,386 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,282,285 | 38,658 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,450,547 | 39,546 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,637,181 | 40,127 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,108,064 | 41,141 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,856,780 | 42,431 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,123,886 | 40,509 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,971,142 | 38,075 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,249,214 | 38,090 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,012,781 | 46,798 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,816,240 | 46,380 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,553,325 | 42,874 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,502,584 | 40,820 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,384,909 | 37,736 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,211,994 | 37,064 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,222,725 | 37,461 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||